Overview

Maraviroc and NeuroAIDS Pathogenesis

Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
Maraviroc is an antiretroviral medication that may help in improving mental function in HIV infected patients with mental problems by decreasing inflammatory tendencies. We will test this in a clinical trial of 42 HIV infected individuals with some mild to moderate mental problems who are already on HIV medications and doing well. We will add Maraviroc or a sugar pill to their HIV medications and see if mental function improves over 48 weeks. This study will be conducted at 2 sites in Hawaii and Puerto Rico.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Hawaii
Collaborators:
University of Puerto Rico
ViiV Healthcare
Treatments:
Maraviroc